首页> 外国专利> RECOMBINANT PROTEIN FOR IDIOPATHIC PULMONARY FIBROSIS TREATMENT OR PREVENTION AND COMPOSITION FOR IDIOPATHIC PULMONARY FIBROSIS TREATMENT OR PREVENTION CONTAINING THEREOF

RECOMBINANT PROTEIN FOR IDIOPATHIC PULMONARY FIBROSIS TREATMENT OR PREVENTION AND COMPOSITION FOR IDIOPATHIC PULMONARY FIBROSIS TREATMENT OR PREVENTION CONTAINING THEREOF

机译:用于特发性肺纤维化治疗或预防的重组蛋白以及用于特发性肺纤维化治疗或预防的重组蛋白

摘要

The present invention is a recombinant protein for preventing or treating idiopathic pulmonary fibrosis recombined based on a milk fat globule-EGF factor 8 (MFG-E8) protein, consisting of the amino acid sequence of SEQ ID NO: 1 to fundamentally treat lung tissues having fibrosis progressed by idiopathic pulmonary fibrosis, thereby being able to recover lung functions to normal levels. In addition, the present invention relates to a pharmaceutical composition which contains the recombinant protein for preventing or treating idiopathic pulmonary fibrosis which is recombined based on the MFG-E8 protein to form the amino acid sequence of SEQ ID NO: 1.
机译:本发明是基于乳脂球-EGF因子8(MFG-E8)蛋白重组或预防的用于治疗特发性肺纤维化的重组蛋白,其由SEQ ID NO:1的氨基酸序列组成,从根本上治疗具有以下特征的肺组织:纤维化是由特发性肺纤维化引起的,因此能够使肺功能恢复到正常水平。另外,本发明涉及包含用于预防或治疗特发性肺纤维化的重组蛋白的药物组合物,所述重组蛋白基于MFG-E8蛋白重组以形成SEQ ID NO:1的氨基酸序列。

著录项

  • 公开/公告号KR20200046869A

    专利类型

  • 公开/公告日2020-05-07

    原文格式PDF

  • 申请/专利权人 NEXEL CO. LTD.;

    申请/专利号KR20180128625

  • 申请日2018-10-26

  • 分类号A61K38/17;A61K38/18;A61K9;A61P11;C07K14/47;C07K14/485;

  • 国家 KR

  • 入库时间 2022-08-21 11:07:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号